PE/Cyanine7 Anti-Human CD40 Antibody[G28.5]

PE/Cyanine7 Anti-Human CD40 Antibody[G28.5]

Introducing the PE/Cyanine7 Anti-Human CD40 Antibody [G28.5], a highly advanced and meticulously engineered product designed to revolutionize the field of immunology. This antibody, meticulously developed using cutting-edge technology, offers unparalleled specificity and sensitivity in detecting the CD40 antigen on human cells.

The PE/Cyanine7 Anti-Human CD40 Antibody [G28.5] showcases exceptional performance characteristics, making it an indispensable tool for researchers and clinicians alike. With its remarkable binding affinity and minimal background noise, this antibody ensures accurate and reliable results, enabling precise identification and characterization of CD40-expressing cells.

Crafted with utmost precision, this antibody exhibits exceptional stability and consistency, ensuring reproducibility across experiments and minimizing variability. Its robust formulation guarantees optimal performance, even under challenging experimental conditions, thereby facilitating seamless integration into diverse research applications.

The PE/Cyanine7 Anti-Human CD40 Antibody [G28.5] is meticulously validated through rigorous quality control measures, ensuring its reliability and reproducibility. Its exceptional specificity and sensitivity make it an ideal choice for flow cytometry, immunohistochemistry, and other immunological techniques, enabling comprehensive analysis of CD40 expression patterns in various biological samples.

Furthermore, this antibody is manufactured in compliance with the highest industry standards, adhering to stringent quality control protocols. Its consistent performance and reliability make it an indispensable tool for researchers and clinicians seeking to unravel the intricate mechanisms underlying CD40-mediated immune responses.

In summary, the PE/Cyanine7 Anti-Human CD40 Antibody [G28.5] represents a breakthrough in immunological research, offering unmatched specificity, sensitivity, and reliability. With its exceptional performance characteristics and meticulous manufacturing process, this antibody is poised to revolutionize the field, empowering researchers and clinicians to unravel the complexities of CD40 biology and pave the way for novel therapeutic interventions.